Literature DB >> 4688430

Serotonin and platelet function in Duchenne muscular dystrophy.

D L Murphy, J R Mendell, W K Engel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4688430     DOI: 10.1001/archneur.1973.00490220047006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

1.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

2.  Spindle induction and differentiation in murine dystrophy.

Authors:  H Yellin
Journal:  Experientia       Date:  1974-03-15

3.  A common uptake system for serotonin and dopamine in human platelets.

Authors:  G S Omenn; L T Smith
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy.

Authors:  H Narukami; K Yoshioka; J Zhao; T Miike
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.

Authors:  Y Dalmaz; L Peyrin; J C Mamelle; D Tuil; R Gilly; J F Cier
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

6.  Effect of serotonin modulation on dystrophin-deficient zebrafish.

Authors:  Janelle M Spinazzola; Matthias R Lambert; Devin E Gibbs; James R Conner; Georgia L Krikorian; Prithu Pareek; Carlo Rago; Louis M Kunkel
Journal:  Biol Open       Date:  2020-08-28       Impact factor: 2.422

Review 7.  Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy.

Authors:  Rebecca A Ellwood; Mathew Piasecki; Nathaniel J Szewczyk
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.